ATH 33.3% 0.4¢ alterity therapeutics limited

Forebrain atrophy in early AD, by Masters et al, page-10

  1. 5,897 Posts.
    lightbulb Created with Sketch. 151
    No worries pivalde. One of my boys bought a parcel of shares, based on positive remarks I made. To be honest I was not so happy with the body language of the docs on the presentation, so checked out the remarks about new brain imaging, and they were spot on. That study I posted actually demonstrated the correlation between brain atrophy and clinical progression. Is there any way you can see this is not a slam dunk? I guess nothing in a neuro trial can b considered slam dunk till final data reports in Jan.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $5.491K 1.520M

Buyers (Bids)

No. Vol. Price($)
39 50987030 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126437200 27
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.